Company / Tangible Book Value per Share
Tandem Diabetes Care Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.34
FY2025
5-year range
$2.34 / $5.74
FY2021-FY2025
Trend
-41.7%
vs FY2024
Sector context
#108 of 158
Health Care
What the data says
At $2.34, Tandem Diabetes Care's tangible book value per share ranks #108 of 158 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $5.74 in FY2022 to $2.34 in FY2025.
Based on SEC 10-K filings.
2.34 in FY2025 with a 5-year CAGR of +1.2%.
Declined from $4.86 to $2.34 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -25.8%
- 5-Year CAGR
- +1.2%
- 10-Year CAGR
- -
Sector benchmark
#108 of 158 in Health CareTop 68% of 158This company $2.34 Sector average $18.47
▼
-87.3% below sector average
Key checks
Key Insights
- Tandem Diabetes Care's tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 41.7% year-over-year.
- Ranks #108 out of 158 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.34 | -41.7% |
| FY2024 | $4.01 | -17.4% |
| FY2023 | $4.86 | -15.3% |
| FY2022 | $5.74 | +83.5% |
| FY2021 | $3.13 | +41.5% |
| FY2020 | $2.21 | +536.4% |
| FY2019 | -$0.51 | +13.5% |
| FY2018 | -$0.59 | -102.9% |
| FY2017 | $20.41 | +10517.3% |
| FY2016 | -$0.20 | -107.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026